A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

NCT02124564 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy
Partial-onset Seizures

Interventions

DRUG: Lacosamide

Sponsor

UCB Japan Co. Ltd.